Archive - February 2018
News from other sources
Study: ‘Wonder drug’ for alcohol abuse may not work
FDA approves new opioid
Pfizer could face £502M bill if it comes up short in U.K. patent appeal for Lyrica
What’s beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Jazz releases some Erwinaze, children’s leukemia drug that has been in short supply
Mired in bribery probe, Novartis Greece office vandalized by anarchist group
R1 RCM to acquire Intermedix Corp.